Atrial fibrillation in the elderly general population: a 30-year follow-up from 70 to 100 years of age

References

• Bjorck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44:3103–3108.
   PubMed Web of Science ®Google Scholar
• Mandalenakis Z, Von Koch L, Eriksson H, et al. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace. 2015;17(7):1018–1022.
   PubMed Web of Science ®Google Scholar
• Andersson P, Londahl M, Abdon NJ, et al. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis. J Intern Med. 2012;272(2):170–176.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042–1046.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364.
   PubMed Web of Science ®Google Scholar
• Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34(14):1061–1067.
   PubMed Web of Science ®Google Scholar
• Lakshminarayan K, Anderson DC, Herzog CA, et al. Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist. 2008;14(3):143–150.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962.
   PubMed Web of Science ®Google Scholar
• Henriksson KM, Farahmand B, Asberg S, et al. Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke. Int J Stroke. 2012;7(4):276–281.
   PubMed Web of Science ®Google Scholar
• Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015;128(5):509–518 e2.
   PubMed Web of Science ®Google Scholar
• Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149(4):657–663.
   PubMed Web of Science ®Google Scholar
• Mandalenakis Z, Lennartsson ST, Fu M, et al. The incidence of atrial fibrillation and the added value of thumb ECG for detecting new cases. Scand Cardiovasc J. 2018;52:256–261.
   PubMed Web of Science ®Google Scholar
• Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring. Scand Cardiovasc J. 2012;46(3):144–148.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476–484.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–844.
   PubMed Web of Science ®Google Scholar
• Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40(1):84–92.
   PubMed Web of Science ®Google Scholar
• Marijon E, Le Heuzey JY, Connolly S, et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013;128(20):2192–2201.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952.
   PubMed Web of Science ®Google Scholar
• Andersson T, Magnuson A, Bryngelsson IL, et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol. 2014;177(1):91–99.
   PubMed Web of Science ®Google Scholar
• Chapa DW, Akintade B, Thomas SA, et al. Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: a systematic review. Heart Lung. 2015;44(3):189–198.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847.
   PubMed Web of Science ®Google Scholar
• Rinder L, Roupe S, Steen B, et al. Seventy-year-old people in Gothenburg: a population study in an industrialized Swedish city. Acta Med Scand. 2009;198(1–6):397–407.
   Google Scholar
• Nilsson LV, Persson G. Prevalence of mental disorders in an urban sample examined at 70, 75 and 79 years of age. Acta Psychiatr Scand. 1984;69(6):519–527.
   PubMed Web of Science ®Google Scholar
• Lernfelt B, Forsberg M, Blomstrand C, et al. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke. 2002;33(1):224–229.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Blackshear JL, Shen WK, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371–378.
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–953.
   PubMed Web of Science ®Google Scholar
• Baturova MA, Lindgren A, Carlson J, et al. Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: How much do we miss?. Europace. 2014;16(12):1714–1719.
   PubMed Web of Science ®Google Scholar
• Svennberg E, Engdahl J, Al-Khalili F, et al. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation. 2015;131(25):2176–2184.
   PubMed Web of Science ®Google Scholar
• Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001;103(5):769–777.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Bertini M, Blomstrom-Lundqvist C, et al. An update on atrial fibrillation in 2014: from pathophysiology to treatment. Int J Cardiol. 2016;203:22–29.
   PubMed Web of Science ®Google Scholar
• Wasmer K, Eckardt L, Breithardt G. Predisposing factors for atrial fibrillation in the elderly. J Geriatr Cardiol. 2017;14(3):179–184.
   PubMedGoogle Scholar
• Leong DP, Eikelboom JW, Healey JS, et al. Atrial fibrillation is associated with increased mortality: causation or association? Eur Heart J. 2013;34(14):1027–1030.
   PubMed Web of Science ®Google Scholar
• Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591–1602.
   PubMed Web of Science ®Google Scholar
• Panaccio MP, Cummins G, Wentworth C, et al. A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records. Clin Epidemiol. 2015;7:77–90.
   PubMed Web of Science ®Google Scholar
• Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909–1917.
   PubMed Web of Science ®Google Scholar
• Ericson L, Bergfeldt L, Bjorholt I. Atrial fibrillation: the cost of illness in Sweden. Eur J Health Econ. 2011;12(5):479–487.
   PubMed Web of Science ®Google Scholar
• Aronsson M, Svennberg E, Rosenqvist M, et al. Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis. Europace. 2017;19(10):1650–1656.
   PubMed Web of Science ®Google Scholar
• Delaney JA, Yin X, Fontes JD, et al. Hospital and clinical care costs associated with atrial fibrillation for Medicare beneficiaries in the Cardiovascular Health Study and the Framingham Heart Study. SAGE Open Med. 2018;6:2050312118759444.
   Web of Science ®Google Scholar
• Vaartjes I, O’Flaherty M, Capewell S, et al. Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke. 2013;44(3):591–597.
   PubMed Web of Science ®Google Scholar
• Lackland DT, Roccella EJ, Deutsch AF, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315–353.
   PubMed Web of Science ®Google Scholar
• Coles AH, Fisher K, Darling C, et al. Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. Am J Cardiol. 2014;114(6):862–868.
   PubMed Web of Science ®Google Scholar
• MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102(10):1126–1131.
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Wang Y, Chen J, et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995–2006. JAMA. 2009;302(7):767–773.
   PubMed Web of Science ®Google Scholar